热门资讯> 正文

Praxis精密药品宣布拟议公开募股

2026-01-07 05:09

Praxis Precision Medicines, Inc.(PRAX) 0

Praxis Precision Medicines (PRAX) announced a proposed public offering of its common stock and, for certain investors, pre-funded warrants in lieu of common stock.
All securities in the offering will be issued and sold by Praxis.
The offering includes a 30-day option for underwriters to purchase up to an additional 15% of the shares (or pre-funded warrants) sold.
Any additional shares would be sold at the public offering price, less underwriting discounts and commissions.

More on Praxis Precision Medicines

Praxis: Priced For Perfection Heading Into 2026
Praxis Precision Medicines: Latest Study Wins Sets Up 2 CNS Drug Approvals In 2026
Praxis: Moving To Strong Buy Based On Ulixacaltamide Success In Treating ET
Praxis rises on ulixacaltamide gaining Breakthrough Therapy status
Praxis, FDA agree on pivotal trial changes for encephalopathy asset elsunersen

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。